Cargando…

Pathogenetic Mechanism of Procalcitonin in COVID-19

How to cite this article: Wiedermann FJ. Pathogenetic Mechanism of Procalcitonin in COVID-19. Indian J Crit Care Med 2021;25(5):594.

Detalles Bibliográficos
Autor principal:	Wiedermann, Franz J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196395/ https://www.ncbi.nlm.nih.gov/pubmed/34177183 http://dx.doi.org/10.5005/jp-journals-10071-23812

Ejemplares similares

Takotsubo syndrome in the setting of COVID-19: Pathogenetic and diagnostic implications
por: Yalta, Kenan, et al.
Publicado: (2022)

Reply to the Letter to the Editor: Takotsubo syndrome in the setting of COVID-19: Pathogenetic and diagnostic implications
por: Rivera, Kristian, et al.
Publicado: (2022)

Experience with procalcitonin use during the COVID-19 pandemic
por: Gonzalez, Laura, et al.
Publicado: (2022)

Inflammatory factors in alveolar lavage fluid from severe COVID-19 pneumonia: PCT and IL-6 in epithelial lining fluid
por: Wiedermann, Franz J., et al.
Publicado: (2021)

5-Fluorouracil-related encephalopathy: at least two distinct pathogenetic mechanisms exist - reply
por: Yeh, Kun-Huei, et al.
Publicado: (1998)

Serum procalcitonin in sepsis
por: Wiwanitkit, Viroj
Publicado: (2011)

Co-existence of Pemphigus Foliaceous and Psoriasis: Is There a Common Pathogenetic Link?
por: Tripathy, Tapaswini, et al.
Publicado: (2021)

Multisystem Inflammatory Syndrome Versus Kawasaki Disease: Potential Differences in Pathogenetic and Clinical Implications
por: Yalta, Kenan, et al.
Publicado: (2023)

Procalcitonin accurately predicts mortality but not bacterial infection in COVID-19 patients admitted to intensive care unit
por: Vanhomwegen, Charlotte, et al.
Publicado: (2021)

Single-centre experience of using procalcitonin to guide antibiotic therapy in COVID-19 intensive care patients
por: Moseley, P., et al.
Publicado: (2022)

Challenges in Procalcitonin Implementation in the Real-World
por: Nguyen, Cynthia T, et al.
Publicado: (2018)

Procalcitonin for the differential diagnosis of COVID-19 in the emergency department. Prospective monocentric study
por: Nazerian, Peiman, et al.
Publicado: (2021)

The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
por: Drewett, George P., et al.
Publicado: (2021)

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?
por: Raineri, Santi Maurizio, et al.
Publicado: (2017)

All that seems sepsis is not sepsis: However, is this case report really a case of catastrophic antiphospholipid syndrome?
por: Stichlberger, Martina, et al.
Publicado: (2014)

ARDS diagnosed by SpO(2)/FiO(2) ratio compared with PaO(2)/FiO(2) ratio: the role as a diagnostic tool for early enrolment into clinical trials
por: Wiedermann, Franz J., et al.
Publicado: (2016)

MicroRNA-155 regulates casein kinase 1 gamma 2: a potential pathogenetic role in chronic lymphocytic leukemia
por: Zhang, T, et al.
Publicado: (2017)

Comment on “CPEO and Mitochondrial Myopathy in a Patient with DGUOK Compound Heterozygous Pathogenetic Variant and mtDNA Multiple Deletions”
por: Finsterer, Josef
Publicado: (2020)

The Role of Procalcitonin Levels in Assessing the Severity of Clostridium Difficile Infection
por: Dazley, Jason, et al.
Publicado: (2015)

Diagnostic Value of Procalcitonin in Predicting Bacteremia in Intensive Care Unit
por: Patnaik, Rupali, et al.
Publicado: (2018)

The clinical usefulness of serum procalcitonin level in patients with scrub typhus
por: Lee, Chang-Seop, et al.
Publicado: (2017)

The dynamics of procalcitonin in COVID-19 patients admitted to Intensive care unit - a multi-centre cohort study in the South West of England, UK.
por: Williams, Philip, et al.
Publicado: (2021)

Blood Procalcitonin Predicts Spontaneous Bacterial Peritonitis in Patients with Cirrhosis and Ascites
por: Asadi Gharabaghi, Mehrnaz, et al.
Publicado: (2015)

Melanosis of the Bladder: Possible Pathogenetic Mechanisms
por: Dupey, Justin E., et al.
Publicado: (2022)

Response of letter to the editor on Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
por: Saikant, R., et al.
Publicado: (2017)

Reply to Letter to the Editor: “Multisystem Inflammatory Syndrome Versus Kawasaki Disease: Potential Differences in Pathogenetic and Clinical Implications”
por: Duman, Derya, et al.
Publicado: (2023)

PATHOGENETIC MECHANISMS IN EXPERIMENTAL IMMUNE FEVER
por: Root, Richard K., et al.
Publicado: (1968)

Pathogenetic mechanisms of heatstroke and novel therapies
por: Bouchama, Abderrezak
Publicado: (2012)

Systemic air embolism causing acute stroke and myocardial infarction after percutaneous transthoracic lung biopsy – a case report
por: Rehwald, Rafael, et al.
Publicado: (2016)

Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4‐factor prothrombin complex concentrates
por: Wiedermann, Christian J.
Publicado: (2020)

Mortality Rate of Sepsis Patients in the Intensive Care Unit: The Prognostic Role of Ejection Fraction and Procalcitonin
por: Hejazi, Mohammad Esmaeil, et al.
Publicado: (2021)

Anti-inflammatory effects of the antibiotics ceftazidime and tobramycin in porcine endotoxin shock: are they really anti-inflammatory?
por: Wiedermann, Franz J
Publicado: (2004)

Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms.
por: Jiang, J. P., et al.
Publicado: (1990)

Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data—authors’ response
por: Llewelyn, Martin J, et al.
Publicado: (2022)

The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2022)

Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients
por: Naeem, Muhammad, et al.
Publicado: (2023)

Clinical Trials in Volume Resuscitation with Hydroxyethyl Starch: Focus on Risk of Bias
por: Wiedermann, Christian Josef
Publicado: (2020)

Extremely elevated serum procalcitonin concentration in a patient with stage IV non-small cell lung cancer
por: Stando, Rafał, et al.
Publicado: (2023)

The Pathogenetic Picture
por: Fincke, B.
Publicado: (1891)

Pathogenetic mechanism of oral granulomatous diseases: An update
por: Abdul, Nishath Sayed
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n8t5vnkf8oaog2bu0h5g5aicoh